BREATHONIX PTE. LTD.
Breath tests for early diagnosis
BREATHONIX PTE. LTD. is a company in medtech based in Singapore, founded in 2019.
Profile
Breathonix aims to save lives through early detecting fatal diseases with affordable, accurate and non-invasive breath tests for disease detection.
With its proprietary breath sampling device and data analysis algorithms, the company has successfully demonstrated early detection of Covid-19 (with over 90% accuracy) and lung cancer (with 80% accuracy) in a clinical study.
Lung cancer is the No.1 cancer killer, accounting for 1.6 million deaths each year. By detecting lung cancer, we are able to increase survival rates from 5% to 80%.
Breathonix was founded by three NUS scientists in 2019, and is supported by NUS GRIP, JUMPStart and StartUp SG.
BREATHONIX PTE. LTD. is positioned in medtech, a segment that rewards a clear, focused offering.
Singapore is where the company is located.
Its current recorded stage is Startup SG directory startup.
The company reports a headcount in the 11 - 50 range.
| Sector | Medtech |
|---|---|
| Country | Singapore |
| Founded | 2019 |
| Employees | 11 - 50 |
| Stage | Startup SG directory startup |
Website: www.breathonix.com
Create a free account